Study in Lancet Oncology shows significant side effect reduction with High Intensity Focused Ultrasound (HIFU) to treat prostate cancer.
High-intensity focused ultrasound (HIFU) is a minimally invasive treatment for prostate cancer. Data from the literature show promising oncological outcomes with a favourable side-effect profile. The aim of this study was to re-evaluate and bring up to date the follow-up of a previously published, prospective trial on HIFU as the primary treatment for prostate cancer.
Uchida, Toyoaki, Muyura Nakano, Sunao Shoji, Yoshihiro Nagata, Yukio Usui, and Toshiro Terachi. “Twelve Years’ Experience with High-intensity Focused Ultrasound (HIFU) Using SonablateTM Devices for the Treatment of Localized Prostate Cancer.” AIP Conference Proceedings 1481, no. 1 (October 3, 2012): 401-406. doi:doi:10.1063/1.4757368.
Elterman, Dean S, Jack Barkin, Sidney B Radomski, Neil E Fleshner, Brian Liu, Kira Bensimon, Samantha Arora, Michael Robinette, and Antonio Finelli. “Results of High Intensity Focused Ultrasound Treatment of Prostate Cancer: Early Canadian Experience at a Single Center.” The Canadian Journal of Urology 18, no. 6 (December 2011): 6037-6042.
Fujisue, Yutaka, Haruhito Azuma, Teruo Inamoto, Kazumasa Komura, Piyush K Agarwal, Hiroshi Masuda, Toshikazu Watsuji, and Yoji Katsuoaka. “Neoadjuvant Hormonal Therapy Does Not Impact the Treatment Success of High-intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer.” World Journal of Urology 29, no. 5 (October 2011): 689-694. doi:10.1007/s00345-010-0628-1.
Uddin Ahmed, Hashim, Paul Cathcart, Venu Chalasani, Andrew Williams, Neil McCartan, Alex Freeman, Alex Kirkham, Clare Allen, Joseph Chin, and Mark Emberton. “Whole-gland Salvage High-intensity Focused Ultrasound Therapy for Localized Prostate Cancer Recurrence After External Beam Radiation Therapy.” Cancer 118, no. 12 (June 15, 2012): 3071-3078. doi:10.1002/cncr.26631.
Inamoto, Teruo, Kazumasa Komura, Toshikazu Watsuji, and Haruhito Azuma. “Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy May Be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer.”Clinical Medicine Insights. Oncology 5 (2011): 101-106. doi:10.4137/CMO.S7073.
Murota-Kawano, Akiko, Mayura Nakano, Sachiko Hongo, Sunao Shoji, Yoshihiro Nagata, and Toyoaki Uchida. “Salvage High-intensity Focused Ultrasound for Biopsy-confirmed Local Recurrence of Prostate Cancer After Radical Prostatectomy.” BJU International 105, no. 12 (June 2010): 1642-1645. doi:10.1111/j.1464-410X.2009.08990.x.
Sumitomo, Makoto, Junichi Asakuma, Hidehiko Yoshii, Akinori Sato, Akio Horiguchi, Keiichi Ito, Kazuhiko Nagakura, and Tomohiko Asano. “Anterior Perirectal Fat Tissue Thickness Is a Strong Predictor of Recurrence After High-intensity Focused Ultrasound for Prostate Cancer.”International Journal of Urology 17, no. 9 (2010): 776-782. doi:10.1111/j.1442-2042.2010.02585.x.
Portalez, Daniel, Pierre Mozer, François Cornud, Raphaëlle Renard-Penna, Vincent Misrai, Matthieu Thoulouzan, and Bernard Malavaud. “Validation of the European Society of Urogenital Radiology Scoring System for Prostate Cancer Diagnosis on Multiparametric Magnetic Resonance Imaging in a Cohort of Repeat Biopsy Patients.” European Urology 62, no. 6 (December 2012): 986-996. doi:10.1016/j.eururo.2012.06.044.
Dickinson, Louise et al. “Image-directed, Tissue-preserving Focal Therapy of Prostate Cancer: a Feasibility Study of a Novel Deformable Magnetic Resonance-ultrasound (MR-US) Registration System: A Novel Deformable MR-US Registration System.” BJU International 112.5 (2013): 594–601. CrossRef. Web. 24 Sept. 2013.